A whole-animal platform to advance a clinical kinase inhibitor into new disease spaceMasahiro Sonoshita, Arvin C. Dar, Alex Scopton et al.|Nature Chemical Biology|2018Cited by 73
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Molecular Cancer Therapeutics|2019Cited by 21
Type II Binders Targeting the “GLR-Out” Conformation of the Pseudokinase STRADαRyan H. B. Smith, Arvin C. Dar, Peter M.U. Ung et al.|Biochemistry|2021Cited by 7
Supplementary Data Tables 1-3 from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0
Supplementary Synthetic Methods from Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC PolypharmacologyJia Xin Yu, Arvin C. Dar, Amanda J. Craig et al.|Unknown|2023Cited by 0